MX2010004620A - Derivados de benzomorfolina y metodos de uso. - Google Patents

Derivados de benzomorfolina y metodos de uso.

Info

Publication number
MX2010004620A
MX2010004620A MX2010004620A MX2010004620A MX2010004620A MX 2010004620 A MX2010004620 A MX 2010004620A MX 2010004620 A MX2010004620 A MX 2010004620A MX 2010004620 A MX2010004620 A MX 2010004620A MX 2010004620 A MX2010004620 A MX 2010004620A
Authority
MX
Mexico
Prior art keywords
methods
diseases
compounds
prophylaxis
processes
Prior art date
Application number
MX2010004620A
Other languages
English (en)
Spanish (es)
Inventor
Raju Subramanian
Jean-Christophe Harmange
Matthew W Martin
Ryan White
Roger Zanon
Jay Larrow
Yohannes Teffera
Joseph F Payack
Mina Dilmeghani Seran
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2010004620A publication Critical patent/MX2010004620A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2010004620A 2007-10-29 2008-10-28 Derivados de benzomorfolina y metodos de uso. MX2010004620A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94807P 2007-10-29 2007-10-29
PCT/US2008/012224 WO2009058267A2 (en) 2007-10-29 2008-10-28 Benzomorpholine derivatives and methods of use

Publications (1)

Publication Number Publication Date
MX2010004620A true MX2010004620A (es) 2010-07-28

Family

ID=40394086

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004620A MX2010004620A (es) 2007-10-29 2008-10-28 Derivados de benzomorfolina y metodos de uso.

Country Status (8)

Country Link
US (1) US7795254B2 (OSRAM)
EP (1) EP2220078B1 (OSRAM)
JP (1) JP5343082B2 (OSRAM)
AU (1) AU2008319366B2 (OSRAM)
CA (1) CA2703257C (OSRAM)
ES (1) ES2417009T3 (OSRAM)
MX (1) MX2010004620A (OSRAM)
WO (1) WO2009058267A2 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684182A5 (de) 1991-10-15 1994-07-29 Escher Wyss Ag Rotationsdruckmaschine.
AU2011254657B2 (en) * 2010-05-19 2016-02-04 Sandoz Ag Preparation of posaconazole intermediates
RU2588570C2 (ru) 2010-05-19 2016-07-10 Сандоз Аг Способ получения хиральных гидразидов
CA2798010C (en) 2010-05-19 2018-09-25 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
CA2838051C (en) 2011-06-16 2019-09-24 Sandoz Ag Process for the preparation of a chiral compound

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755332A (en) * 1971-07-01 1973-08-28 Ciba Geigy Corp Substituted 4 indazolaminoquinolines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
GB9323290D0 (en) * 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
AU4547396A (en) 1995-01-31 1996-08-21 Zenyaku Kogyo Kabushiki Kaisha Thioquinoline derivatives
GB9505702D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd Fungicidal compounds
GB9505651D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
US6143764A (en) * 1995-11-07 2000-11-07 Kirin Beer Kabushiki Kaisha Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same
ATE201873T1 (de) * 1995-11-14 2001-06-15 Pharmacia & Upjohn Spa Aryl- und heteroaryl- purin- und pyridopyrimidin- derivate
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
DE19614718A1 (de) * 1996-04-15 1997-10-16 Hoechst Schering Agrevo Gmbh Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel
GB9800575D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
US6573289B1 (en) * 1998-04-23 2003-06-03 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
EP1105378B1 (en) * 1998-08-21 2005-03-30 Parker Hughes Institute Quinazoline derivatives
TR200500745T2 (tr) * 1999-02-10 2005-05-23 Astrazeneca Ab Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
US6258820B1 (en) * 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
BR0010599A (pt) * 1999-04-12 2002-02-13 Aventis Pharma Ltd Compostos de heteroarila bicìclicos substituìdos como antagonistas de integrina
WO2002030924A1 (en) * 2000-10-13 2002-04-18 Astrazeneca Ab Quinazoline derivatives with anti-tumour activity
MX242553B (es) * 2000-10-20 2006-12-06 Eisai Co Ltd Derivados aromaticos que contienen nitrogeno.
KR100883731B1 (ko) * 2001-06-22 2009-02-12 기린 파마 가부시끼가이샤 간세포 증식 인자 수용체 자기 인산화를 저해하는 퀴놀린유도체 및 퀴나졸린 유도체 및 이들을 함유하는 의약 조성물
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
ATE423104T1 (de) * 2001-11-03 2009-03-15 Astrazeneca Ab Quinazolin derivate als antitumor-mittel
PL371486A1 (en) * 2002-02-01 2005-06-13 Astrazeneca Ab Quinazoline compounds
US7645878B2 (en) * 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
EA007987B1 (ru) * 2002-03-29 2007-02-27 Чирон Корпорейшн Замещённые бензазолы и их применение в качестве ингибиторов киназы raf
CN1688549A (zh) * 2002-08-23 2005-10-26 麒麟麦酒株式会社 具有TGFβ抑制活性的化合物和含所述化合物的药用组合物
EP1603884A4 (en) * 2003-02-28 2008-05-28 Encysive Pharmaceuticals Inc PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE AND NAPHTHALENE UROTENSIN II RECEPTOR ANTAGONISTS
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
US7531553B2 (en) * 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
GB0310401D0 (en) * 2003-05-07 2003-06-11 Astrazeneca Ab Therapeutic agent
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
UA86614C2 (ru) * 2004-01-23 2009-05-12 Амген Инк Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата
JO2787B1 (en) * 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use

Also Published As

Publication number Publication date
AU2008319366A1 (en) 2009-05-07
CA2703257A1 (en) 2009-05-07
AU2008319366B2 (en) 2012-03-01
US20090149454A1 (en) 2009-06-11
WO2009058267A3 (en) 2010-06-10
US7795254B2 (en) 2010-09-14
WO2009058267A2 (en) 2009-05-07
ES2417009T3 (es) 2013-08-05
JP2011502147A (ja) 2011-01-20
EP2220078A2 (en) 2010-08-25
CA2703257C (en) 2013-02-19
EP2220078B1 (en) 2013-05-22
JP5343082B2 (ja) 2013-11-13

Similar Documents

Publication Publication Date Title
MX2010007683A (es) Derivados heterociclicos fusionados y metodos de uso como inhibidores de c-met.
MY167135A (en) Fused heterocyclic derivatives and methods of use
MX2009006543A (es) Compuestos heterociclicos y su uso en el tratamiento de la inflamacion, angiogenesis y cancer.
WO2008086014A3 (en) Bis-aryl amide derivatives useful for the treatment of cancer
MX2009008531A (es) Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
TW200716596A (en) Substituted amide derivatives and methods of use
WO2008079291A3 (en) Substituted heterocycles and methods of use
TNSN06228A1 (en) Compounds and methods of use
WO2007048070A3 (en) Pyrrolo-pyridine derivatives for the treatment of cancer diseases
ATE404552T1 (de) Substituierte isochinolinderivate und anwendungsverfahren
WO2007005668A3 (en) Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
ATE453636T1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
MX2012000565A (es) Derivados de triterpeno tipo lupeol como antivirales.
WO2004005279A3 (en) Substituted anthranilic amide derivatives and methods of use
IN2012DN00971A (OSRAM)
ATE540038T1 (de) Heterocyclen als proteinkinaseinhibitoren
GEP20135806B (en) Lactams as beta secretase inhibitors
ZA200600579B (en) Piperazine derivatives and methods of use
MX2012001134A (es) Composiciones y metodos para inhibicion de la via jak.
WO2009109501A3 (en) Ocular pharmaceutical compositions
IN2013DN02555A (OSRAM)
MX2010004620A (es) Derivados de benzomorfolina y metodos de uso.
MX367327B (es) Formulaciones, sales y polimorfos de transnorsertralina y usos de los mismos.
PH12012501476A1 (en) Aminoquinoline derivatives
WO2006041888A3 (en) Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents

Legal Events

Date Code Title Description
FG Grant or registration